Relevance of EGFR Between Serum VEGF and MMP-9 in Primary Hepatocellular Carcinoma Patients with Transarterial Chemoembolization

Shengya Cao1 Department of Clinical laboratory, Xuzhou Cancer Hospital, Xuzhou, Jiangsu221005, People’s Republic of China

Shuo Zhu2 Department of Hepatobiliary Surgery, Xuzhou Cancer Hospital, Xuzhou, Jiangsu221005, People’s Republic of China

Wei Yin1 Department of Clinical laboratory, Xuzhou Cancer Hospital, Xuzhou, Jiangsu221005, People’s Republic of China

Heng Xu3 Laboratory of Pharmaceutical Chemistry, Jiangsu Province Institute of Materia Medica, Nanjing Tech University, Nanjing, Jiangsu210000, People’s Republic of China

Jianzhong Wu4 Research Center for Clinical Oncology, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu210000, People’s Republic of ChinaCorrespondence[email protected]

Qiang Wang1 Department of Clinical laboratory, Xuzhou Cancer Hospital, Xuzhou, Jiangsu221005, People’s Republic of China;5 Department of Radiotherapy, Xuzhou Cancer Hospital, Xuzhou, Jiangsu221005, People’s Republic of ChinaCorrespondence[email protected]

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Relevance of EGFR Between Serum VEGF and MMP-9 in Primary Hepatocellular Carcinoma Patients with Transarterial Chemoembolization

Articles from other publishers (3)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Relevance of EGFR Between Serum VEGF and MMP-9 in Primary Hepatocellular Carcinoma Patients with Transarterial Chemoembolization

Citations (3)

Articles from other publishers (3)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date